AAN News » Industry News
   

New Regs for RX Ads on the Way?

By AAN Staff
december 4, 2003  08:38 am
The Federal Trade Commission wants the Federal Drug Administration to drop its requirements that pharmaceutical print ads run detailed drug side-effects listings. Instead, it wants drug companies to be allowed to use the same kind of "brief summary" risk warnings in print ads that are now used in broadcast commercials.
View full article at Advertising Age